Servier and X-Chem Announce Drug Discovery Collaboration in Neurological Diseases Paris and Waltham, Mass.; Jan. 6, 2021 (Business Wire) – Servier, a global pharmaceutical Group and X-Chem, Inc., a privately held drug discovery company announced today a partnership to identify and develop novel small molecules for the treatment of neurological disorders. Under the terms of […]
